These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26195285)

  • 1. Antiangiogenic activity of herboxidiene via downregulation of vascular endothelial growth factor receptor-2 and hypoxia-inducible factor-1α.
    Jung HJ; Kim Y; Shin JY; Sohng JK; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1728-35. PubMed ID: 26195285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-1α expression.
    Han JM; Lim HN; Jung HJ
    Oncol Rep; 2017 Dec; 38(6):3430-3438. PubMed ID: 29039561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic potentials of ahpatinins obtained from a Streptomyces species.
    Han JM; Jang JP; Jang JH; Ahn JS; Jung HJ
    Oncol Rep; 2020 Feb; 43(2):625-634. PubMed ID: 31894333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.
    Dewangan J; Srivastava S; Mishra S; Divakar A; Kumar S; Rath SK
    Biochem Pharmacol; 2019 Jun; 164():326-335. PubMed ID: 31028743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cyclic hexapeptides from Penicillium sp. FN070315 with antiangiogenic activities.
    Jang JP; Jung HJ; Han JM; Jung N; Kim Y; Kwon HJ; Ko SK; Soung NK; Jang JH; Ahn JS
    PLoS One; 2017; 12(9):e0184339. PubMed ID: 28950026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
    Xie SR; Wang Y; Liu CW; Luo K; Cai YQ
    Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro.
    Han JM; Kwon HJ; Jung HJ
    Int J Oncol; 2016 Oct; 49(4):1497-504. PubMed ID: 27498749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo.
    Kim Y; Jung HJ; Kwon HJ
    Biochem Biophys Res Commun; 2012 Jan; 417(1):330-4. PubMed ID: 22155252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaetoglobosin K inhibits tumor angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxia-inducible factor 1α.
    Luo H; Li B; Li Z; Cutler SJ; Rankin GO; Chen YC
    Anticancer Drugs; 2013 Aug; 24(7):715-24. PubMed ID: 23695013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
    Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
    J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
    Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
    Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.